News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,734 Results
Type
Article (44700)
Company Profile (254)
Press Release (672779)
Multimedia
Podcasts (67)
Webinars (14)
Section
Business (206924)
Career Advice (2126)
Deals (35936)
Drug Delivery (103)
Drug Development (82821)
Employer Resources (174)
FDA (16567)
Job Trends (15129)
News (350739)
Policy (33380)
Tag
Academia (2684)
Accelerated approval (10)
Adcomms (24)
Allergies (100)
Alliances (50415)
ALS (114)
Alzheimer's disease (1506)
Antibody-drug conjugate (ADC) (160)
Approvals (16541)
Artificial intelligence (322)
Autoimmune disease (29)
Automation (18)
Bankruptcy (369)
Best Places to Work (11761)
BIOSECURE Act (20)
Biosimilars (126)
Biotechnology (177)
Bladder cancer (95)
Brain cancer (35)
Breast cancer (374)
Cancer (2921)
Cardiovascular disease (217)
Career advice (1781)
Career pathing (32)
CAR-T (196)
CDC (32)
Cell therapy (513)
Cervical cancer (23)
Clinical research (67993)
Collaboration (1036)
Company closure (3)
Compensation (686)
Complete response letters (25)
COVID-19 (2764)
CRISPR (61)
C-suite (331)
Cystic fibrosis (111)
Data (3002)
Decentralized trials (2)
Denatured (20)
Depression (69)
Diabetes (356)
Diagnostics (6631)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (137)
Drug pricing (130)
Drug shortages (31)
Duchenne muscular dystrophy (128)
Earnings (87849)
Editorial (46)
Employer branding (21)
Employer resources (151)
Events (114907)
Executive appointments (861)
FDA (18219)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (952)
Gene editing (135)
Generative AI (25)
Gene therapy (389)
GLP-1 (839)
Government (4659)
Grass and pollen (4)
Guidances (181)
Healthcare (19166)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (159)
Immuno-oncology (9)
Indications (39)
Infectious disease (2944)
Inflammatory bowel disease (153)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (121)
Interviews (344)
IPO (16743)
IRA (47)
Job creations (3756)
Job search strategy (1502)
Kidney cancer (13)
Labor market (52)
Layoffs (520)
Leadership (22)
Legal (8118)
Liver cancer (82)
Lung cancer (408)
Lymphoma (212)
Machine learning (11)
Management (60)
Manufacturing (388)
MASH (97)
Medical device (13646)
Medtech (13651)
Mergers & acquisitions (19915)
Metabolic disorders (890)
Multiple sclerosis (98)
NASH (20)
Neurodegenerative disease (127)
Neuropsychiatric disorders (36)
Neuroscience (2209)
NextGen: Class of 2025 (6658)
Non-profit (4601)
Now hiring (47)
Obesity (457)
Opinion (246)
Ovarian cancer (101)
Pain (106)
Pancreatic cancer (123)
Parkinson's disease (193)
Partnered (22)
Patents (298)
Patient recruitment (164)
Peanut (53)
People (58625)
Pharmaceutical (64)
Pharmacy benefit managers (23)
Phase I (21221)
Phase II (29914)
Phase III (22330)
Pipeline (1641)
Policy (207)
Postmarket research (2651)
Preclinical (9019)
Press Release (68)
Prostate cancer (144)
Psychedelics (39)
Radiopharmaceuticals (260)
Rare diseases (477)
Real estate (6050)
Recruiting (66)
Regulatory (23139)
Reports (50)
Research institute (2427)
Resumes & cover letters (356)
Rett syndrome (9)
RNA editing (8)
RSV (53)
Schizophrenia (90)
Series A (163)
Series B (115)
Service/supplier (11)
Sickle cell disease (63)
Special edition (20)
Spinal muscular atrophy (156)
Sponsored (33)
Startups (3740)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (60)
The Weekly (45)
Vaccines (833)
Venture capital (55)
Weight loss (287)
Women's health (46)
Worklife (16)
Date
Today (43)
Last 7 days (398)
Last 30 days (1842)
Last 365 days (31647)
2025 (16919)
2024 (35668)
2023 (40592)
2022 (51781)
2021 (56299)
2020 (54771)
2019 (47277)
2018 (35664)
2017 (32830)
2016 (32343)
2015 (38256)
2014 (31979)
2013 (27052)
2012 (29272)
2011 (29872)
2010 (28016)
Location
Africa (761)
Alabama (62)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (39352)
Australia (6513)
California (7448)
Canada (2358)
China (684)
Colorado (321)
Connecticut (319)
Delaware (196)
Europe (85498)
Florida (1126)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (641)
India (26)
Indiana (363)
Iowa (16)
Japan (227)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1025)
Massachusetts (5559)
Michigan (246)
Minnesota (454)
Mississippi (3)
Missouri (91)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (67)
New Jersey (2080)
New Mexico (29)
New York (2101)
North Carolina (1093)
North Dakota (8)
Northern California (3276)
Ohio (236)
Oklahoma (16)
Oregon (35)
Pennsylvania (1615)
Puerto Rico (17)
Rhode Island (36)
South America (1138)
South Carolina (34)
South Dakota (1)
Southern California (2782)
Tennessee (125)
Texas (1125)
United States (27685)
Utah (221)
Virginia (184)
Washington D.C. (72)
Washington State (632)
West Virginia (4)
Wisconsin (75)
717,734 Results for "earli inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led firms to make tough pipeline decisions early in the development process. The result may be costly for all of us.
May 21, 2025
·
5 min read
·
Michael N. Abrams
Press Releases
INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
June 26, 2025
·
5 min read
Press Releases
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability to Distinguish Early Lung Cancer from Other Non-Cancerous Lung Diseases
May 12, 2025
·
4 min read
Press Releases
ACCC Rural Appalachian Lung Cancer Screening Initiative Fuels Increased, Early Cancer Detection
June 18, 2025
·
2 min read
Press Releases
First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy
Trial is expected to provide key insights on safety, tolerability and immune system response for its THT treatment of late-stage melanoma patients
July 7, 2025
·
4 min read
Press Releases
Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
May 20, 2025
·
10 min read
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
Press Releases
Celcuity Reports Clinical Data from Two Early Phase Studies of Gedatolisib
July 1, 2025
·
7 min read
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and ViiV will push forward with their long-acting antivirals after touting positive early-stage results.
March 12, 2025
·
2 min read
·
Tristan Manalac
1 of 71,774
Next
